InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer
InMode (Nasdaq: INMD) announced key leadership changes effective immediately.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InMode (Nasdaq: INMD) announced key leadership changes effective immediately. Dr. Shlomo Nass was appointed Chairman of the Board, succeeding retired chairman Dr. Michael Anghel. InMode also promoted Moshik Itzkovich, formerly Senior Vice President of Finance, to Chief Financial Officer, replacing Yair Malca, who will remain as a consultant through the Annual General Meeting to support a smooth transition.
Positive
- Appointment of experienced governance expert Dr. Shlomo Nass as board chairman
- Internal promotion of Moshik Itzkovich to CFO supports leadership continuity
- Former CFO Yair Malca staying as consultant through AGM to aid transition
- Company highlights strong balance sheet and financial foundations built under outgoing CFO
Negative
- Concurrent changes in chairman and CFO roles create a period of leadership transition
Details
News Market Reaction – INMD
On May 20, the day this news came out, INMD closed 0.36% above the previous close.
Data tracked by StockTitan Argus for the May 20 session.
Historical Context
-
Announced participation in Barclays and Jefferies investor events and webcasts.
-
Reported Q1 revenue growth, strong margins, cash and buybacks with 2026 guidance.
-
Pre-announced Q1 revenue range and reiterated full-year 2026 revenue guidance.
-
Disclosed CEO and CFO presentation at Needham Virtual Healthcare Conference.
-
Authorized new buyback for up to about 10% of shares outstanding using cash.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YOKNEAM,
Dr. Nass succeeds Dr. Michael Anghel, who retired earlier this month, and will lead the Board in supporting the Company's long-term strategic growth and governance priorities. Dr. Nass brings decades of expertise in corporate law, accounting, governance, and audit oversight, with extensive experience advising public and private companies on complex regulatory and financial matters.
"We are pleased to welcome Shlomo as Chairman of the Board," said Moshe Mizrahy, Chief Executive Officer. "His deep expertise in corporate governance, financial oversight, and regulatory matters, combined with his extensive leadership experience, will be invaluable as we continue to execute our strategic priorities and drive long-term shareholder value."
"On behalf of the Board and management team, we thank Michael Anghel for his many years of commitment and service to InMode and wish him all the best going forward," Mizrahy concluded.
At the same time, InMode announced the appointment of Moshik Itzkovich as Chief Financial Officer. Moshik has held senior finance roles at InMode and was previously Senior Vice President of Finance. He replaces Yair Malca, who stepped down earlier this month and will serve as a consultant at least through the Company's Annual General Meeting to ensure a smooth transition.
"Having partnered closely with Yair over the last three years, Moshik brings continuity, financial expertise, and strategic insight to this role," said Moshe Mizrahy, Chief Executive Officer. "We are confident he is well positioned to build on our strong financial foundation and support the Company's long-term objectives."
"We thank Yair for his many years of exceptional service. His leadership and contributions have been instrumental to our success, and he played a key role in our transition to a publicly traded Company. He leaves InMode with a very strong balance sheet and solid operational and financial foundations in place for his successor. We are grateful for his lasting impact on the Company," Mizrahy concluded.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
Logo - https://mma.prnewswire.com/media/1064477/5978883/InMode_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-appoints-dr-shlomo-nass-as-chairman-of-the-board-and-moshik-itzkovich-as-chief-financial-officer-302776826.html
SOURCE InMode LTD
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.